Literature DB >> 16708379

Determination of human plasma protein binding of baicalin by ultrafiltration and high-performance liquid chromatography.

Yihong Tang1, Haiyan Zhu, Yuanyuan Zhang, Chenggang Huang.   

Abstract

A simple and selective HPLC assay was developed and utilized for determination of human plasma protein binding of baicalin. The method involved solid-phase extraction and reversed-phase chromatographic separation with a mobile phase of acetonitrile-0.02 mol/L phosphate buffer (pH 2.5; 25:75, v/v) and UV detection at 276 nm. The standard curve for baicalin was linear over the concentration range 0.1-20 microg/mL and the limit of detection was 0.02 microg/mL. The absolute recovery was greater than 76%. The intra-day and inter-day variations were less than 10%. Ultrafiltration technique was applied to determining the plasma protein binding of baicalin in human plasma. Results show the plasma protein binding of baicalin was in the range 86-92% over all the concentrations studied and the protein binding association constant was determined to be 1.21 x 10(5) L/mol at 4 degrees C.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16708379     DOI: 10.1002/bmc.655

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  13 in total

1.  Preparation, Characterization and in vivo Study of Borneol-Baicalin-Liposomes for Treatment of Cerebral Ischemia-Reperfusion Injury.

Authors:  Yulu Zhang; Songyu Liu; Jinyan Wan; Qiyue Yang; Yan Xiang; Li Ni; Yu Long; Mingquan Cui; Zhimin Ci; Donglei Tang; Nan Li
Journal:  Int J Nanomedicine       Date:  2020-08-12

Review 2.  Baicalein, Baicalin, and Wogonin: Protective Effects against Ischemia-Induced Neurodegeneration in the Brain and Retina.

Authors:  Li Pan; Kin-Sang Cho; Irvin Yi; Chi-Ho To; Dong Feng Chen; Chi-Wai Do
Journal:  Oxid Med Cell Longev       Date:  2021-06-29       Impact factor: 7.310

3.  Comparative pharmacokinetics of baicalin, wogonoside, baicalein and wogonin in plasma after oral administration of pure baicalin, radix scutellariae and scutellariae-paeoniae couple extracts in normal and ulcerative colitis rats.

Authors:  Zhen-Qiu Zhang; Wei Liua; Li Zhuang; Jing Wang; Shuai Zhang
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

4.  Preclinical Pharmacokinetics, Tissue Distribution, and Plasma Protein Binding of Sodium (±)-5-Bromo-2-(α-Hydroxypentyl) Benzoate (BZP), an Innovative Potent Anti-ischemic Stroke Agent.

Authors:  Xin Tian; Hong-Meng Li; Jing-Yao Wei; Bing-Jie Liu; Yu-Hai Zhang; Gao-Ju Wang; Jun-Biao Chang; Hai-Ling Qiao
Journal:  Front Pharmacol       Date:  2016-08-18       Impact factor: 5.810

5.  Inhibitory Effects of Baicalin on the Expression and Activity of CYP3A Induce the Pharmacokinetic Changes of Midazolam in Rats.

Authors:  Xin Tian; Zhen-Yu Cheng; Han Jin; Jie Gao; Hai-Ling Qiao
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-24       Impact factor: 2.629

6.  Concentration-dependent inhibitory effect of Baicalin on the plasma protein binding and metabolism of chlorzoxazone, a CYP2E1 probe substrate, in rats in vitro and in vivo.

Authors:  Na Gao; Dan Zou; Hai-Ling Qiao
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

7.  Contribution of baicalin on the plasma protein binding displacement and CYP3A activity inhibition to the pharmacokinetic changes of nifedipine in rats in vivo and in vitro.

Authors:  Zhen-Yu Cheng; Xin Tian; Jie Gao; Hong-Meng Li; Lin-Jing Jia; Hai-Ling Qiao
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

8.  Pharmacokinetic-Pharmacodynamic Analysis on Inflammation Rat Model after Oral Administration of Huang Lian Jie Du Decoction.

Authors:  Wei Ren; Ran Zuo; Yao-Nan Wang; Hong-Jie Wang; Jian Yang; Shao-Kun Xin; Ling-Yu Han; Hai-Yu Zhao; Shu-Yan Han; Bo Gao; Hao Hu; Yuan-Jia Hu; Bao-Lin Bian; Nan Si
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

Review 9.  The Effects of Baicalin and Baicalein on Cerebral Ischemia: A Review.

Authors:  Wei Liang; Xiaobo Huang; Wenqiang Chen
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

Review 10.  Study on the interaction between active components from traditional Chinese medicine and plasma proteins.

Authors:  Qishu Jiao; Rufeng Wang; Yanyan Jiang; Bin Liu
Journal:  Chem Cent J       Date:  2018-05-04       Impact factor: 4.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.